Indefinite Delivery Contract SPE2DB22D9209

The Defense Logistics Agency awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc. to provide pharmaceutical products and medical supplies on an as-needed basis. The contract has a potential value of $499,999,999 and a period of performance through December 31, 2025.

Task orders issued against the contract by DLA between January 18, 2023 and August 30, 2022 require DMS Pharmaceutical to deliver a variety of pharmaceutical products to locations in Park Ridge, Illinois. These products include medications such as Botox, Nexplanon implants, antibiotics, anti-itch cream, and others. The task orders range in value from $16 to over $2 million and utilize firm fixed price terms, with periods of performance varying from one to over twenty days. No set-aside provisions or subcontracting requirements were specified in the materials provided.

As the prime vendor, DMS Pharmaceutical Group Inc. will supply pharmaceuticals and medical consumables to support the Defense Logistics Agency's global logistics operations. DLA is responsible for procuring and distributing these critical supplies to military treatment facilities and contingency environments worldwide. The task orders awarded appear to replenish standard pharmaceutical inventory levels and fulfill ongoing treatment needs within the military health system, in line with DLA's mission to ensure materiel readiness for all military services.